Lina Albitar: all publications

• Publications

  • Albitar L, Carter MB, Davies S, and Leslie KK. Consequences of the Loss of P53, RB1, and PTEN: Relationship to Gefitinib Resistance in Endometrial Cancer. Gynecologic Oncology. 106(1) , 94-104 (2007)

  • Albitar L, Pickett G, Morgan M, Davies S, and Leslie KK. Models Representing Type I and Type II Human Endometrial Cancers:Ishikawa H and Hec50co Cells. Gynecologic Oncology. ; 106(1) , 52-64 (2007)

  • Albitar L, Laidler L., Abdallah R, and Leslie KK. Regulation of Signaling Phosphoproteins by Epidermal Growth Factor and Iressa (ZD1839) in Human Endometrial Cancer Cells that Model Type I and II Tumors Molecular Cancer Therapeutics 4 (12) , 1891-9 (2005)

  • Dai D, Albitar L, Nguyen T, Laidler L, Singh M, and Leslie KK. A Therapeutic Model for Advanced Endometrial Cancer: Systemic Progestin in Combination with Local Adenoviral Mediated Progesterone Receptor Expression Molecular Cancer Therapeutics. 4 (1) , 169-75 (2005)

  • Leslie KK, Laidler L, Albitar L, Davies S, Holmes A, Nguyen T, Bolnick J, Dai D. Tyrosine Kinase Inhibitors in Endometrial Cancer International Journal of Gynecological Cancer 15 (2) , 409-411 (2005)

  • Peabody DS, Albitar L. Isolation of Viral Coat Protein Mutants with Altered Assembly and Aggregation Properties Nucleic Acids Res. 29 (22) , 113-120 (2001)